Literature DB >> 26194170

Isolation and Characterization of Multipotential Mesenchymal Stromal Cells from Congenital Pseudoarthrosis of the Tibia: Case Report.

Dylana Diaz-Solano1, Olga Wittig1, Jose D Mota2, Jose E Cardier1.   

Abstract

Congenital pseudoarthrosis of the tibia (CPT) is an uncommon disease whose etiology and pathogenesis is unknown. Several evidences suggest that decreased osteogenic capacities, impaired local vascularization, and microenvironment alterations may play a role in the pathogenesis of CPT. Additionally, it is not clear if the pathogenesis of this disease is related to the absence of cells with osteogenic capacity of differentiation. In this work, a two-year-old patient diagnosed with CPT underwent an orthopedic surgery to promote bone union in a pseudoarthrosis lesion. Tissue from CPT lesion was excised, and histological evaluation and tissue culture were performed. Histologic analysis of the soft CPT lesion showed the presence of highly cellular fibrous tissue, vascularization, and abundant extracellular matrix. Fusiform cells of mesenchymal appearance were observed but osteoblasts, osteoclasts, chondrocytes, and adipose cells were not found. There was no evidence of osteogenesis. CPT tissue cultured as explants showed, after one month of culture, evidence of osteogenesis, chondrogenesis, and adipogenesis. Cells isolated from explants of CPT tissue showed a fibroblast-like morphology and expressed the mesenchymal stromal cell (MSC) markers: CD105, CD73, and CD90 (CPT-MSC). Functional analysis showed that CPT-MSC differentiate, in vitro, into osteogenic, chondrogenic, and adipocytic cells. CPT-MSC expressed osteocalcin and agrecan. CPT-MSC produced collagen in the presence of ascorbic acid. MSC from BM of normal individuals were used as control. In summary, our results indicate that CPT tissue contains MSC with osteogenic capacity of differentiation. It is possible that CPT microenvironment may contribute to impair the osteogenic capacity of differentiation of CPT-MSC.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  MSC; congenital; pseudoarthrosis; tibia

Mesh:

Year:  2015        PMID: 26194170     DOI: 10.1002/ar.23198

Source DB:  PubMed          Journal:  Anat Rec (Hoboken)        ISSN: 1932-8486            Impact factor:   2.064


  5 in total

1.  Functional characteristics of mesenchymal stem cells derived from the adipose tissue of a patient with achondroplasia.

Authors:  Jeong-Ran Park; Hanbyeol Lee; Chung-Hyo Kim; Seok-Ho Hong; Kwon-Soo Ha; Se-Ran Yang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-04-08       Impact factor: 2.416

2.  Identification and characterization of NF1 and non-NF1 congenital pseudarthrosis of the tibia based on germline NF1 variants: genetic and clinical analysis of 75 patients.

Authors:  Guanghui Zhu; Yu Zheng; Yaoxi Liu; An Yan; Zhengmao Hu; Yongjia Yang; Shiting Xiang; Liping Li; Weijian Chen; Yu Peng; Nanbert Zhong; Haibo Mei
Journal:  Orphanet J Rare Dis       Date:  2019-09-18       Impact factor: 4.123

3.  The effects of vasoactive intestinal peptide on RANKL-induced osteoclast formation.

Authors:  Hongyi Qu; Yan Zhuang; Lin Zhu; Zuohui Zhao; Kelai Wang
Journal:  Ann Transl Med       Date:  2021-01

4.  Evaluation of bone marrow-derived mesenchymal stem cell quality from patients with congenital pseudoarthrosis of the tibia.

Authors:  Ismail Hadisoebroto Dilogo; Fajar Mujadid; Retno Wahyu Nurhayati; Aryadi Kurniawan
Journal:  J Orthop Surg Res       Date:  2018-10-23       Impact factor: 2.359

5.  Serum-derived exosomes from neurofibromatosis type 1 congenital tibial pseudarthrosis impaired bone by promoting osteoclastogenesis and inhibiting osteogenesis.

Authors:  Ge Yang; Hui Yu; Yaoxi Liu; Weihua Ye; Guanghui Zhu; An Yan; Qian Tan; Haibo Mei
Journal:  Exp Biol Med (Maywood)       Date:  2020-10-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.